Cargando…

Construction and validation of a macrophage polarization-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is a highly heterogeneous disease and the current prognostic system cannot meet the clinical need. Interactions between immune responsiveness and tumor cells plays a key role in the progression of TNBC and macrophages are vital component of immune cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Hanjia, Hong, Ruoxi, Xu, Yadong, Zheng, Qiufan, Xia, Wen, Lu, Qianyi, Jiang, Kuikui, Xu, Fei, Chen, Miao, Shi, Dingbo, Deng, Wuguo, Wang, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005976/ https://www.ncbi.nlm.nih.gov/pubmed/36915811 http://dx.doi.org/10.21037/gs-23-6

Ejemplares similares

CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
por: Lee, Kaping, et al.
Publicado: (2021)

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population
por: Wang, Liye, et al.
Publicado: (2021)

Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors
por: Jiang, Kuikui, et al.
Publicado: (2023)

Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes
por: Jiang, Kuikui, et al.
Publicado: (2023)

Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer
por: Zhou, Danyang, et al.
Publicado: (2021)

Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer
por: Zhang, Kai, et al.
Publicado: (2020)

Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center
por: Lu, Qianyi, et al.
Publicado: (2020)

Local treatment for liver oligometastases in breast cancer patients: identification of prognostic factors and exploration of appropriate treatment strategy
por: Jiang, Kuikui, et al.
Publicado: (2020)

The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence
por: Zhou, Danyang, et al.
Publicado: (2023)

Miller–Payne Grading and 70-Gene Signature Are Associated With Prognosis of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer After Neoadjuvant Chemotherapy
por: Wang, Liye, et al.
Publicado: (2021)

Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study
por: Xu, Fei, et al.
Publicado: (2020)

Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
por: Qin, Ge, et al.
Publicado: (2015)

Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus
por: Duan, Fangfang, et al.
Publicado: (2021)

The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer
por: Zhou, Danyang, et al.
Publicado: (2023)

NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
por: Qin, Ge, et al.
Publicado: (2020)

Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis
por: Zhang, Kai, et al.
Publicado: (2018)

SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer
por: Zhu, Anjie, et al.
Publicado: (2016)

Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer
por: Su, Peng, et al.
Publicado: (2021)

G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer
por: Hollmén, Maija, et al.
Publicado: (2015)

Significant response to margetuximab in Chinese HER2-positive metastatic breast cancer patient who progressed after second-line targeted therapy
por: Li, Jiaping, et al.
Publicado: (2023)

Hyperthermia promotes M1 polarization of macrophages via exosome-mediated HSPB8 transfer in triple negative breast cancer
por: Xu, Di, et al.
Publicado: (2023)

Overall survival of triple negative breast cancer in French Caribbean women
por: Beaubrun-Renard, Murielle Murielle, et al.
Publicado: (2022)

Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer
por: Lin, Fei, et al.
Publicado: (2023)

Anemoside A3 Inhibits Macrophage M2-Like Polarization to Prevent Triple-Negative Breast Cancer Metastasis
por: Liu, Peng, et al.
Publicado: (2023)

What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database
por: Ni, Mengqian, et al.
Publicado: (2023)

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
por: Santoro, Marco, et al.
Publicado: (2022)

Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer
por: Ferrucci, Veronica, et al.
Publicado: (2020)

Association of Adjuvant Chemotherapy With Overall Survival Among Women With Small, Node-Negative, Triple-Negative Breast Cancer
por: Oladeru, Oluwadamilola T., et al.
Publicado: (2020)

Association between obesity with disease-free survival and overall survival in triple-negative breast cancer: A meta-analysis
por: Mei, Lin, et al.
Publicado: (2018)

Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
por: Guo, Lin-Wei, et al.
Publicado: (2018)

Macrophages with Different Polarization Phenotypes Influence Cementoblast Mineralization through Exosomes
por: Zhao, Yi, et al.
Publicado: (2022)

Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer
por: Tan, Abel H. Y., et al.
Publicado: (2019)

Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery
por: Lin, Wei-Xun, et al.
Publicado: (2022)

Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study
por: Hong, Ruoxi, et al.
Publicado: (2021)

Construction of Development Momentum Index of Financial Technology by Principal Component Analysis in the Era of Digital Economy
por: Li, Boran, et al.
Publicado: (2022)

Macrophage Colony-stimulating Factor Mediates the Recruitment of Macrophages in Triple negative Breast Cancer
por: Lu, Xiaoqing, et al.
Publicado: (2019)

Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study
por: Ma, Yuyu, et al.
Publicado: (2022)

Genomic Index of Sensitivity to Chemotherapy for Triple Negative Breast Cancer
por: C, Ahammad Sameer, et al.
Publicado: (2023)

Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries
por: Zhu, Wenjie, et al.
Publicado: (2015)

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer
por: Cao, Xu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4v65gv8104aijtps5r5hdsr508